Recently, increasing evidences have shown similar association between the abnormally regulated RAS, increased proinflammatory cytokines production, and NF-κB activation along with increased ROS generation as well as upregulated TLR4 contributing to end-organ damage in DN. The gene discussed is TLR4; the disease is liver dysplastic nodule.